# rtPA in in the Prevention of CVAD-Associated Thrombosis and Infection in Pediatric Patients With Short Bowel Syndrome

> **NCT02355743** · PHASE4 · COMPLETED · sponsor: **Lynn Malec** · enrollment: 8 (actual)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** rtPA lock therapy

## Key facts

- **NCT ID:** NCT02355743
- **Lead sponsor:** Lynn Malec
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-01
- **Primary completion:** 2016-09-03
- **Final completion:** 2016-09-03
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2018-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02355743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02355743, "rtPA in in the Prevention of CVAD-Associated Thrombosis and Infection in Pediatric Patients With Short Bowel Syndrome". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02355743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*